VanEck Australian Floating Rate ETF vs FMC Corp — how do they compare? VanEck Australian Floating Rate ETF trades at $50.96 (market cap $11.24B), while FMC Corp trades at $8.3 (market cap $1.39B). The key difference: VanEck Australian Floating Rate ETF is far larger — about 8.1× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while VanEck Australian Floating Rate ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Australian Floating Rate ETF for 21 Days and FMC Corp for 68 Days on average.
| FLOT | FMC | |
|---|---|---|
Market Cap | $11.24B | $1.39B |
Volume | 1,872,962 | 4,145,979 |
Sector | Fixed Income | Basic Materials |
52-Week High | $51.07 | $30.63 |
52-Week Low | $50.72 | $8.44 |
Typical Hold Time | 21 Days | 68 Days |
Enterprise Value | — | $5.19B |
Dividend Yield | — | 3.59% |
Signals from Pluang's Aura AI — not financial advice
FLOT trades at $50.91 with minimal daily movement (-0.02%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. Recent dividend distributions of $0.17-$0.18 highlight income generation. The ETF benefits from floating rate exposure amid Fed tightening cycles, though concentration risk in bank holdings (47% exposure) warrants attention.
Outlook remains tied to interest rate trajectory, with FLOT positioned to benefit from higher rates. Key risks include bank sector concentration and Fed policy shifts. The current technical weakness suggests cautious near-term momentum despite the floating rate advantage in rising rate environments.
FMC trades at $8.36, down 8.03% in the past 24 hours, reflecting bearish technical signals and weak profitability. The company reported a net loss of -$2.24B in 2025, with negative margins and declining revenue. Recent news includes a regulatory filing for rimisoxafen in Brazil and a minority equity investment by Tessenderlo Group. Cash flow trends show volatility, with 2025 net cash flow positive at $227M but driven by financing activities.
The outlook remains challenging due to persistent losses and high debt, though analyst consensus suggests upside with a $14.60 price target. Key risks include execution on deleveraging, cyclical industry pressures, and competitive threats. Investment opportunity hinges on successful turnaround efforts and new product approvals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →